Argent Biopharma Ltd (MGCLF)

[GonzoinHD]

What has just come to mind is the idea that although CannEpil is reportedly formulated to target patients with refractory epilepsy (30% of all epilepsy patients) there’s a great chance it could also be beneficial and greatly improve the quality of life of the remaining 70% as well. Interesting action today, I continue to buy more as the opportunity presents itself. I doubt I have as many as BostinErin, but I got a few, and I hope to grab a few more down here before this pony makes it to the chute.

GO MGCLF